Mar 23, 2026 07:15AM Royalty Pharma names Lucas Glass as head of artificial intelligence

Mar 17, 2026 04:02PM Royalty Pharma hires Bank of America healthcare banking executive

Mar 2, 2026 06:01AM Zymeworks secures $250 million in royalty-backed financing from Royalty Pharma

Feb 27, 2026 01:43PM Royalty Pharma (RPRX) PT Raised to $50 at TD Cowen

Feb 12, 2026 05:52AM BofA Securities Reiterates Buy Rating on Royalty Pharma (RPRX)

Feb 11, 2026 04:57PM Royalty Pharma plc (RPRX) Reports Q4 results

Jan 30, 2026 04:16AM UBS Upgrades Royalty Pharma (RPRX) to Buy

Jan 12, 2026 07:15AM Royalty Pharma reports $4.7 billion in transactions for 2025

Jan 12, 2026 04:07AM Royalty Pharma provides up to $500 million for TEVA vitiligo drug

Jan 12, 2026 04:04AM TEVA secures $500 million funding from Royalty Pharma for vitiligo drug

Jan 9, 2026 08:32AM Royalty Pharma plc (RPRX) Raises Quarterly Dividend 7.3% to $0.235; 2.3% Yield

Dec 29, 2025 04:42PM Royalty Pharma acquires remaining Evrysdi royalty for $240 million

Dec 22, 2025 04:16PM Royalty Pharma names McGivern as chief legal officer

Dec 16, 2025 07:15AM Royalty Pharma acquires drug royalty rights for up to $315 million

Dec 11, 2025 10:12AM Royalty Pharma (RPRX) PT Raised at TD Cowen; 'Best Ideas 2026: Unique Business'

Dec 4, 2025 07:02AM Denali Therapeutics secures $275 million royalty deal with Royalty Pharma

Nov 6, 2025 04:13AM Royalty Pharma (RPRX) PT Raised to $45 at Goldman Sachs

Nov 4, 2025 07:15AM Royalty Pharma acquires AMVUTTRA royalty for $310 million

Sep 30, 2025 05:07AM Goldman Sachs Starts Royalty Pharma (RPRX) at Buy, PT $42

Sep 29, 2025 08:16AM Royalty Pharma names Dr. Ted Love as lead independent director

Sep 16, 2025 09:42AM Royalty Pharma (RPRX) PT Raised to $38 at UBS, But Firm on Sidelines Due to Structural Issues

Sep 12, 2025 09:16AM TD Cowen Reiterates Buy Rating on Royalty Pharma (RPRX)

Sep 3, 2025 05:44AM Royalty Pharma prices $2 billion senior unsecured notes offering

Sep 2, 2025 07:15AM Royalty Pharma provides up to $300 million to Zenas BioPharma for obexelimab

Aug 25, 2025 06:01AM BeOne Medicines sells IMDELLTRA royalty rights for up to $950 million

Aug 13, 2025 04:15PM Henry Fernandez steps down from Royalty Pharma board

Aug 6, 2025 12:23PM Royalty Pharma (RPRX) PT Raised to $48 at BofA Securities

Jul 22, 2025 05:02AM Royalty Pharma (RPRX) PT Raised to $42 at Citi

Jul 18, 2025 08:15AM Royalty Pharma plc (RPRX) Declares $0.22 Quarterly Dividend; 2.5% Yield

Jul 17, 2025 08:15AM Royalty Pharma adds two independent directors to board

Jun 24, 2025 07:06AM Royalty Pharma plc (RPRX) and Revolution Medicines (RVMD) Enter Into Funding Agreements for Up to $2 Billion

May 16, 2025 06:12AM Morgan Stanley Reinstates Royalty Pharma (RPRX) at Overweight

May 12, 2025 04:17PM Royalty Pharma plc (RPRX) Announces Shareholder Approval of its External Manager Acquisition

May 12, 2025 04:15PM Royalty Pharma plc (RPRX) Announces Shareholder Approval of its External Manager Acquisition

Apr 8, 2025 04:15PM Royalty Pharma (RPRX) appoints Vlad Coric to Board

Mar 27, 2025 09:24AM UBS Reiterates Neutral Rating on Royalty Pharma (RPRX)

Mar 27, 2025 08:29AM Citi Reiterates Buy Rating on Royalty Pharma (RPRX)

Feb 12, 2025 06:30AM Royalty Pharma plc (RPRX) Announces R&D Funding Collaboration With Biogen

Feb 11, 2025 07:54AM Royalty Pharma (RPRX) Reports Q4 Revenue of $594 million

Jan 29, 2025 09:04AM Royalty Pharma (RPRX) Announces Sale of MorphoSys Development Funding Bonds

Jan 14, 2025 02:22PM Royalty Pharma plc (RPRX) 2900 contracts of July 32.50 calls trade

Jan 10, 2025 07:16AM Royalty Pharma (RPRX) Announces Acquisition of its External Manager and $3 Billion Share Repurchase Program

Jan 7, 2025 11:00AM TD Cowen on Pharma: '10 Events in 2025 That Could Change Practice, Alter Companies, Move Stocks'

Nov 7, 2024 07:11AM Royalty Pharma plc (RPRX) to Acquire Royalty Interest in Geron’s (GERN) RYTELO for $125M

Nov 4, 2024 04:02PM Syndax Pharmaceuticals (SNDX) and Royalty Pharma (RPRX) Enter $350M Royalty Funding Agreement for Niktimvo

Oct 11, 2024 08:15AM Royalty Pharma plc (RPRX) Declares $0.21 Quarterly Dividend; 3.1% Yield

Oct 7, 2024 09:28AM TD Cowen Reiterates Buy Rating on Royalty Pharma (RPRX)

Sep 4, 2024 07:44AM Goldman Sachs Reiterates Buy Rating on Royalty Pharma (RPRX)

Sep 3, 2024 05:07PM Ascendis Pharma (ASND) and Royalty Pharma (RPRX) Enter $150M Royalty Funding Agreement

Jul 17, 2024 04:18PM Royalty Pharma plc (RPRX) Declares $0.21 Quarterly Dividend; 3% Yield